Comparison of platelet hemostasis effects for angiotensin receptor blockers in patients with arterial hypertension and metabolic syndrome

The authors compared platelet hemostasis effects for two angiotensin receptor blockers, valsartan and eprosartan, in patients with arterial hypertension (AH) and metabolic syndrome (MS). For 16 weeks, 34 patients received valsartan, and 32 - eprosartan. Plasma and platelet lipid peroxidation product...

Full description

Bibliographic Details
Main Authors: I. N. Medvedev, T. A. Kumova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2007-08-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2201